Written questions by Mierlo.

Media and Sport, if she will hold discussions with Ofcom on the effectiveness of the regulatory principles used to determine if an investigation should be carried out into comments made by media outlets.

Ofcom, by law, carries out its investigations independently of the Government. Ofcom is accountable to Parliament, and the standards and objectives which underpin Ofcom’s rules and procedures are set out in legislation. Decisions over whether or not to investigate particular media outlets, and how they do that, are rightly a matter for Ofcom.

What funding she has allocated to tackle the asylum case backlog.

The Home Office does not have a separately identifiable budget for tackling the asylum case backlog. All costs involved are scored against Home Office business-as-usual budgets that cover all asylum cases regardless of age. You may find Home Office annual reports and accounts - GOV.UK useful, more specifically, the latest 2025 report and the accompanying core data table.You can also see Migration transparency data - GOV.UK, table ASY_04 of Immigration and Protection data which contains information on the cost of asylum.

Whether her Department has made an assessment of the potential impact of the appointment of Immigration Adjudicators on the asylum backlog.

The Home Secretary confirmed in a statement to the House of Commons on 1 September that further information regarding Tribunal system reforms will be provided in due course. The statement can be accessed here: Borders and Asylum - Hansard - UK Parliament.

What discussions he has had with Immigration and Asylum Tribunal Judges on the introduction of independent adjudicators to hear asylum appeals.

It is standard practice not to comment on the specifics of discussions between ministers and the judiciary.As would be expected, the Lord Chancellor has regular meetings with the Lady Chief Justice and other senior judges.In line with constitutional conventions, discussions with the judiciary do not cover the merits of policy proposals and are limited to technical matters relating to the operation of the courts and the wider administration of justice.

What plans her Department has to ensure that funding through the School Rebuilding Programme is spent in line with (a) net zero standards and (b) sustainability goals.

The department commits to a wide range of actions in our Sustainability and Climate Change Strategy, including a requirement that all new school buildings we deliver are net-zero carbon in operation and are adapted to climate change. The strategy can be accessed at: https://www.gov.uk/government/publications/sustainability-and-climate-change-strategy.All schools funded through the School Rebuilding Programme (SRP) have been designed to meet this standard, supporting the UK’s 25-year Environment Plan by requiring all projects to increase their level of greening in support of biodiversity net gain. The design principles of our output specification for SRP will ensure sites are more resilient to the impact of climate change and buildings delivered will achieve net zero carbon in operation.

Communities and Local Government, what steps he is taking to improve transparency in the purchasing property process.

On 6 October 2025, the government published a consultation on proposals to improve to the home buying and selling process. It can be found on gov.uk here.The consultation includes proposals to require sellers and estate agents to provide upfront property information. This might include information relating to leasehold terms, property condition, and purchasing chains.Under the Digital Markets, Competition and Consumers Act 2024, property listings must already not omit information that the average consumer needs to make an informed transactional decision.

Communities and Local Government, what steps he is taking to ensure that management companies are maintaining newly built developments to agreed standards.

Estate management companies will usually agree standards for maintaining newly built developments with the developer at the time that the site is handed over to them. Where these standards are replicated in the agreement between the estate manager and the homeowner, failure to deliver services to this standard may be a breach of contract . In such instances, homeowners are able to make an application to the County Court to seek resolution. In some instances, standards may be set through planning conditions and a failure to meet them may also be a breach of planning control. Local planning authorities have a wide range of enforcement powers, with strong penalties for non-compliance, which they can use where development is not maintained in accordance with the planning permission granted. It is for authorities to decide how and when they use their powers depending on the circumstances of each case. The government remain committed to protecting residential freeholders on private and mixed-tenure housing estates from unfair charges. This year we will consult on implementing the Leasehold and Freehold Reform Act’s new consumer protection provisions for the up to 1.75m homes that are subject to these charges, and bring these measures into force as quickly as possible thereafter. These include ensuring that homeowners who pay an estate management charge have better access to information they need to understand what they are paying for, the right to challenge the reasonableness at the First-tier Tribunal (in England), and to go to the tribunal to appoint a substitute manager. The government is determined to end the injustice of ‘fleecehold’ entirely and we will consult this year on legislative and policy options to reduce the prevalence of private estate management arrangements, which are the root cause of the problems experienced by many residential freeholders.

Communities and Local Government, what steps he is taking to assist local planning authorities in holding management companies to account for the maintenance of (a) roads and (b) public spaces under their remit.

Estate management companies will usually agree standards for maintaining newly built developments with the developer at the time that the site is handed over to them. Where these standards are replicated in the agreement between the estate manager and the homeowner, failure to deliver services to this standard may be a breach of contract . In such instances, homeowners are able to make an application to the County Court to seek resolution. In some instances, standards may be set through planning conditions and a failure to meet them may also be a breach of planning control. Local planning authorities have a wide range of enforcement powers, with strong penalties for non-compliance, which they can use where development is not maintained in accordance with the planning permission granted. It is for authorities to decide how and when they use their powers depending on the circumstances of each case. The government remain committed to protecting residential freeholders on private and mixed-tenure housing estates from unfair charges. This year we will consult on implementing the Leasehold and Freehold Reform Act’s new consumer protection provisions for the up to 1.75m homes that are subject to these charges, and bring these measures into force as quickly as possible thereafter. These include ensuring that homeowners who pay an estate management charge have better access to information they need to understand what they are paying for, the right to challenge the reasonableness at the First-tier Tribunal (in England), and to go to the tribunal to appoint a substitute manager. The government is determined to end the injustice of ‘fleecehold’ entirely and we will consult this year on legislative and policy options to reduce the prevalence of private estate management arrangements, which are the root cause of the problems experienced by many residential freeholders.

What steps he is taking to ensure medicine shortages do not impact clinicians' ability to prescribe medicines that are best suited to the patient.

The resilience of UK supply chains is a key priority, and we are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages. In August, the Government published a policy paper, ‘Managing a robust and resilient supply of medicines’, which outlines the steps the Department and NHS England are taking to enhance resilience in our supply chains. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency, and other colleagues across the supply chain as we progress work to co-design and deliver these actions. While we cannot always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they arise and mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols (SSPs), and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals including pharmacists, so they can advise and support their patients.

What steps he is taking to decrease the level of the impact of medicine shortages on patients.

The resilience of UK supply chains is a key priority, and we are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages. In August, the Government published a policy paper, ‘Managing a robust and resilient supply of medicines’, which outlines the steps the Department and NHS England are taking to enhance resilience in our supply chains. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency, and other colleagues across the supply chain as we progress work to co-design and deliver these actions. While we cannot always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they arise and mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols (SSPs), and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals including pharmacists, so they can advise and support their patients.

Media and Sport, whether she has had discussions with the BBC Board on the UK's participation in the Eurovision Song Contest in the context of Israel's participation.

The BBC is operationally and editorially independent from the Government. Therefore, the Government cannot intervene in the BBC’s day-to-day operations including on editorial matters.Decisions on who to include in international events and competitions are for the organisers to take, within the framework of their own rules and regulations. It is for the EBU, in consultation with its members, to decide which countries are allowed to participate in Eurovision.

What steps his Department is taking to support NHS patient transport for (a) elderly people and (b) other patients.

Non-Emergency Patient Transport Services (NEPTS) are designed to provide transport for patients who have particular clinical or mobility needs that necessitate such support, which may include elderly or vulnerable patients. The eligibility criteria for NEPTS have been set nationally by NHS England, and the details are available at the following link: https://www.england.nhs.uk/wp-content/uploads/2022/05/B1244-nepts-eligibility-criteria.pdf The Healthcare Travel Cost Scheme (HTCS) is available for eligible patients and provides financial support to facilitate journeys to and from National Health Service funded secondary care. Details on the eligibility for HTCS is available at the following link:https://www.nhs.uk/nhs-services/help-with-health-costs/healthcare-travel-costs-scheme-htcs/.Local integrated care boards (ICBs) hold responsibility for the implementation of patient transport services at a local level, including monitoring and improving against performance targets. ICBs are best placed to work and consult with their local stakeholders, health and care organisations, and local authorities to decide how to best meet and deliver for the needs of their local population. NHS England is funding and co-ordinating a range of Patient Transport Pathfinder projects to explore more effective approaches to supporting patients with their NHS travel needs.

If he will make an assessment of the adequacy of his Department's processes for (a) forecasting, (b) alerting and (c) responding to medicine shortages.

Medicine supply chains are complex, global and highly regulated and there are a number of reasons why supply can be disrupted – many of which are not specific to the United Kingdom and are outside of government control. This includes manufacturing difficulties, access to raw materials, sudden demand spikes or distribution issues, and regulatory issues.The resilience of UK supply chains is a key priority, and we are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages. In August, the government published a policy paper, ‘Managing a robust and resilient supply of medicines’, which provides transparency of the supply chains we rely on, the actions we take to protect patients from medicines shortages when they occur, and the steps the Department and NHS England are taking to enhance resilience in our supply chains. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency, and other colleagues across the supply chain as we progress work to co-design and deliver these actions.

If he will make an assessment of the potential impact of NHS tariff thresholds on pharmacies' ability to source medicines.

Evaluations by the National Institute for Health and Care Excellence (NICE) ensure that spend on new medicines represents a clinically and cost-effective use of National Health Service resources.NICE thresholds should not have any impact on pharmacies’ ability to source medicines. Community pharmacies source the drugs they need to dispense against NHS prescriptions and will be reimbursed according to the prices and arrangements set out in the Drug Tariff. The United Kingdom has well established ways of managing the cost of medicines, ensuring pharmacies are appropriately reimbursed and clear processes in place to protect against risks to supply.

Innovation and Technology, whether she will make an assessment of the effectiveness of the enforcement of the Malicious Communications Act 1988.

The Online Safety Act introduced a number of communication offences, which were commenced in January 2024, including the false and threatening communications offences. The new communications offences have replaced the equivalent offences in the Malicious Communications Act 1988. In the January to December 2024 period, there were 14 convictions under the false communications offence and 294 under the threatening communications offence.

What assessment he has made of the effectiveness of the fortnightly notification provided to medicine suppliers regarding medicine shortages.

NHS England’s medicines frameworks contain a contractual ask that requires all suppliers to update NHS England on their ability to supply their products to National Health Service hospitals. This information is requested fortnightly and the responses are the basis by which NHS England’s medicines supply chain team assess current or potential upcoming medicines shortages. This is a process designed to ensure the continuity of medicines supply for NHS hospitals and the information is not shared openly, but rather is only shared with specific relevant suppliers, who may be able to assist with the proposed mitigation plan. A compilation of the mitigations is shared with all NHS hospitals and regional pharmacy procurement leads in order to support the implementation of the agreed actions locally.

What recent assessment he has made of the robustness of protections for patient advocates' (a) personal care interactions with NHS services and (b) their advocacy for patients.

For people who find it difficult to understand their care or find it hard to speak up, ‘Someone to speak up for you advocates’ are available to act as a spokesperson for them. They can help with a wide range of support needs, including understanding the care and support process, helping with decisions and standing up for a patient’s rights. People can access this support through their local council.Advocacy support is also available for anyone who wants to make a complaint about the National Health Service. Local authorities have a legal obligation to provide an Independent Complaints Advocacy Service to support people who are making or thinking about making a complaint. An NHS complaints advocate can provide support at any stage of the complaints process. The Government is providing approximately £15 million of grant funding to local authorities this year towards this service.

What steps is he taking to reduce the level of medicine access inequalities in England; and what discussions he has had with his counterparts in the devolved Administrations on this matter.

The National Institute for Health and Care Excellence (NICE) is the independent body that develops authoritative, evidence-based guidance on whether new medicines should be routinely funded by the National Health Service in England based on an evaluation of clinical and cost effectiveness. The NHS in England is legally required to fund medicines recommended by NICE, normally within three months of the publication of final guidance, which supports consistent access for NHS patients wherever in England they live.Fit for the future: 10 Year Health Plan for England, published on 3 July 2025, describes the creation of a single national formulary (SNF) for medicines to supersede the current process by which each local area decides which medicines, in addition to those recommended by NICE, are available to its patients. A SNF is expected to supersede these local processes with a formulary oversight board responsible for sequencing products included in the SNF based on clinical and cost effectiveness, supported by NICE. The intention is to drive rapid and equitable adoption of the most clinically and cost-effective medicines.Work will now begin on design and delivery planning, and we will work collaboratively with key stakeholders including NICE and industry on the plans.The devolved administrations are responsible for the arrangements that they put in place to make decisions on access to medicines for NHS patients, however, this Department’s officials engage and meet with them regularly in a spirit of collaboration and mutual learning. At the political level, health ministers from the four nations also meet quarterly.

Communities and Local Government, whether he has had recent discussions with the Environment Agency on their process for approving a planning application in the case of new development in Oxfordshire that will be connected to Oxford Sewage Treatment Works.

MHCLG ministers have had no recent discussions with the Environment Agency (EA) in respect of the matter in question.The EA has worked with Thames Water to develop a strategic approach to managing wastewater capacity challenges in Oxford. Working with local partners, it is tracking delivery of the improvements to the Oxford Sewage Treatment Works to ensure the delivery of sufficient wastewater capacity in this critical growth area.

What discussions he has had with his international counterparts on (a) the suitability of country-level forecasts of supply needs for medicines up to three years in advance and (b) the steps needed to reduce medicine shortages from unexpected rises in demand including for (i) Attention Deficit Hyperactivity Disorder and (ii) hormone replacement therapy.

Given the inherent global nature of medical supply chains, international collaboration is key to strengthening supply resilience. The United Kingdom is committed to working with international partners to enhance the resilience and security of medical supply chains. We regularly engage with international partners, bilaterally and multilaterally, to exchange information on approaches to strengthen medical supply chains including approaches to manage and reduce shortages. The Department and the Medicines and Healthcare products Regulatory Agency (MHRA) both participate in the Drug Shortages Global Regulatory Working Group, an international forum of medicine regulatory authorities from the UK alongside Australia, Canada, Japan, the United States and the European Medicines Agency, with the World Health Organisation as an observer. Information is shared about shortages of medicines with a global impact, including medicines used for Attention Deficit Hyperactivity Disorder (ADHD), and actions are taken to prevent, monitor and mitigate their impact. While we cannot always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they arise and mitigate risks to patients. We continue to work closely with suppliers and other stakeholders such as the National Health Service and MHRA to maintain supply of medicines used for ADHD and Hormone Replacement Treatment (HRT) across the UK during any shortages. This includes working to expedite resupply dates of the disrupted products to resolve issues as soon as possible and engaging with new suppliers of medicines to increase supply capacity and resilience, to help fill supply gaps and prevent future shortages. As a result of intensive work, the supply issues affecting medicines used for ADHD and HRT are now largely resolved.